Results 31 to 40 of about 7,045,458 (313)

Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease. [PDF]

open access: yes, 2013
Cystic Fibrosis associated liver disease (CFLD) develops in approximately 30% of CF patients. However, routine sensitive diagnostic tools for CFLD are lacking. Within this study, we aimed to identify new experimental biomarkers for the detection of CFLD.
Richard Schulz   +26 more
core   +1 more source

The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial

open access: yesTrials, 2020
Objectives A variety of possible mechanisms can make the nucleic acid test of patients who meet the discharge conditions positive again, including reinfection, reactivation of the original virus, lack of strict discharge criteria, new infection, and so ...
Jiawen Li   +4 more
doaj   +1 more source

COVID-19-induced multisystem inflammatory syndrome in a child with Wilson disease: a case report

open access: yesEgyptian Liver Journal, 2022
Background Infection with coronavirus disease 2019 (COVID-19) can progress to the multisystem inflammatory syndrome in children (MIS-C). Patients with liver cirrhosis are at increased risk of complications.
Tawhida Yassin Abdel-Ghaffar   +7 more
doaj   +1 more source

Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression

open access: yesBMC Cancer, 2017
Background Tumor metastasis often occurs in hepatocellular carcinoma (HCC) and influences the patient’s prognosis, and microRNAs are reported to play key roles in tumor metastasis.
Shuzhen Chang   +4 more
doaj   +1 more source

Autoimmune Liver Disease Associated With Celiac Disease in Childhood: A Multicenter Study

open access: yes, 2008
Patients with autoimmune liver disease might have a hidden celiac disease, suggesting a rigorous check in any cryptogenic liver ...
VAJRO P   +5 more
core   +1 more source

Physicians Infrequently Adhere to Hepatitis Vaccination Guidelines for Chronic Liver Disease [PDF]

open access: yes, 2013
Background and Goals:Hepatitis A (HAV) and hepatitis B (HBV) vaccination in patients with chronic liver disease is an accepted standard of care. We determined HAV and HBV vaccination rates in a tertiary care referral hepatology clinic and the impact of ...
Dhiraj Yadav   +15 more
core   +2 more sources

Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes [PDF]

open access: yes, 2023
Background/aims: Metabolic dysfunction-associated fatty liver disease (MAFLD) is categorized into three subtypes: overweight/obese (OW), lean/normal weight with metabolic abnormalities, and diabetes mellitus (DM).
임태섭, 김승업, 김자경
core   +1 more source

Hepatic Innervations and Nonalcoholic Fatty Liver Disease

open access: yes, 2023
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder. Increased sympathetic (noradrenergic) nerve tone has a complex role in the etiopathomechanism of NAFLD, affecting the development/progression of steatosis, inflammation ...
Roberto Gramignoli   +13 more
core   +1 more source

Using a machine learning model to risk stratify for the presence of significant liver disease in a primary care population [PDF]

open access: yes, 2023
Background: Current strategies for detecting significant chronic liver disease (CLD) in the community are based on the extrapolation of diagnostic tests used in secondary care settings.
Hanley, Neil A.   +11 more
core   +1 more source

Adipokines and redox signaling: impact on fatty liver disease. [PDF]

open access: yes, 2011
Adipokines (adipose tissue cytokines) are polypeptide factors secreted by adipose tissue in a highly regulated manner. The 'classical' adipokines (leptin, adiponectin, and resistin) are expressed only by adipocytes, but other adipokines have been shown ...
Marra, Fabio.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy